Metropolitan Life Insurance Company (MetLife)’s Verso Corporation VRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,451
Closed -$174K 2792
2021
Q4
$174K Hold
6,451
﹤0.01% 2116
2021
Q3
$134K Sell
6,451
-2,343
-27% -$45.2K ﹤0.01% 2353
2021
Q2
$156K Buy
8,794
+875
+11% +$14.4K ﹤0.01% 2329
2021
Q1
$116K Buy
7,919
+4,004
+102% +$52.7K ﹤0.01% 2360
2020
Q4
$47.1K Sell
3,915
-1,820
-32% -$18K ﹤0.01% 2486
2020
Q3
$45.2K Sell
5,735
-5,583
-49% -$67.9K ﹤0.01% 2476
2020
Q2
$135K Hold
11,318
﹤0.01% 2070
2020
Q1
$128K Hold
11,318
﹤0.01% 1878
2019
Q4
$204K Sell
11,318
-541
-5% -$8.68K ﹤0.01% 1915
2019
Q3
$147K Hold
11,859
﹤0.01% 2087
2019
Q2
$226K Hold
11,859
﹤0.01% 1819
2019
Q1
$254K Hold
11,859
﹤0.01% 1739
2018
Q4
$266K Buy
11,859
+515
+5% +$13.9K 0.01% 1624
2018
Q3
$382K Hold
11,344
0.01% 1556
2018
Q2
$247K Buy
11,344
+1,604
+16% +$30.6K ﹤0.01% 1802
2018
Q1
$164K Hold
9,740
﹤0.01% 2021
2017
Q4
$171K Buy
+9,740
New +$93.1K ﹤0.01% 1999

Other funds holding VRS

Metropolitan Life Insurance Company (MetLife)'s VRS Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Verso Corporation (VRS) in Q1 2022, closing a stake of 6,451 shares — an estimated $174K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VRS in Q4 2017 and held it in 17 quarters. The position peaked at $382K in Q3 2018. 20 funds tracked by Wall St. Rank hold VRS as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Verso Corporation position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,451 Verso Corporation shares in Q1 2022, an estimated $174K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Verso Corporation in Q4 2017 and held it in 17 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Verso Corporation position peaked at $382K in Q3 2018.
  • 20 funds tracked by Wall St. Rank held Verso Corporation as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.